Corbus Pharmaceuticals Holdings, Inc. Paid-in-Kind Interest
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Paid-in-Kind Interest of $0 for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2016-03-28
- Corbus Pharmaceuticals Holdings, Inc. paid-in-kind interest for the quarter ending 2014-12-31 was $6.82K, a 33.50% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. paid-in-kind interest for the quarter ending 2014-09-30 was $650.00.
- Corbus Pharmaceuticals Holdings, Inc. paid-in-kind interest for the quarter ending 2014-06-30 was $11.23K.
- Corbus Pharmaceuticals Holdings, Inc. paid-in-kind interest for the quarter ending 2014-03-31 was $11.16K.
- Corbus Pharmaceuticals Holdings, Inc. paid-in-kind interest for fiscal 2014 was $29.86K, a 28.12% decline from fiscal 2013.
- Corbus Pharmaceuticals Holdings, Inc. paid-in-kind interest for fiscal 2013 was $41.54K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-11-10 | |||
| 2014-12-31 | $6.82K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $7.47K derived: sum of 2 quarters · filed 2016-03-28 | $18.70K derived: sum of 3 quarters · filed 2016-03-28 | $29.86K 10-K · filed 2016-03-28 |
| 2014-09-30 | $650.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $11.88K derived: sum of 2 quarters · filed 2015-11-10 | $23.05K 10-Q · filed 2015-11-10 | $33.30K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $11.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $22.39K 10-Q · filed 2015-08-13 | $32.65K derived: sum of 3 quarters · filed 2015-08-13 | |
| 2014-03-31 | $11.16K 10-Q · filed 2015-05-13 | $21.41K derived: sum of 2 quarters · filed 2015-05-13 | ||
| 2013-12-31 | $10.25K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | $41.54K 10-K · filed 2015-02-10 | ||
| 2013-09-30 | $31.29K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |